- Report
- October 2024
- 180 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2024
- 174 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- June 2022
- 130 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- April 2023
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
The Bovine Tuberculosis (TB) Diagnosis market is a segment of the Animal Healthcare/Veterinary industry. It focuses on the diagnosis and treatment of TB in cattle, which is a major cause of economic losses in the livestock industry. Diagnosis of TB in cattle is typically done through a combination of clinical signs, laboratory tests, and post-mortem examination. Tests used to diagnose TB in cattle include the single intradermal comparative cervical tuberculin test, the single intradermal comparative cervical tuberculin test with gamma interferon, and the single intradermal comparative cervical tuberculin test with gamma interferon and ELISA.
The Bovine Tuberculosis Diagnosis market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include IDEXX Laboratories, Inc., Neogen Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Zoetis, Inc. Show Less Read more